CXCR4 and breast carcinoma: Patients with BAG3 high/CXCR4 high showed worse overall survival than those with BAG3 high/CXCR4 low (Figure 7f), confirming the involvement of CXCR4 in oncogenic function of BAG3 in breast cancer.